Our Nine Research Priorities

The AGITG research priorities and strategic activities drive our efforts to accelerate the pace of discovery and connect researchers working across institutions and disciplines. The challenges of treating gastro-intestinal (GI) cancers are vast and the impact that these diseases have is devastating.

Set by the Scientific Advisory Committee, the priorities look to identify the areas of greatest need and ideas that have the potential to significantly improve the knowledge base for clinical decision-making.

The current list reflects AGITG’s Research Strategy – to undertake a strategic, multidisciplinary, program-based, collaborative clinical trials portfolio to improve outcomes for patients with GI cancer. It focuses on proactively building the clinical trial portfolio, maximising recruitment and funding opportunities, fostering multidisciplinary national and international collaborations, maintaining and supporting a multidisciplinary membership base and maintaining efficient and cost-effective structures and processes for optimal use of resources.

The research priorities are reviewed annually with input from the AGITG membership. Over time, they will evolve with the cancer research landscape and to reflect advancing science and unmet clinical needs.

We are currently addressing our research priorities in the following ways:

  • Expanding access to clinical trials in remote, regional and rural areas by incorporating Tele-Trial sites where feasible.
  • Implementing an e-consent platform to increase patient access to trials.
  • Engaging with industry to discuss research opportunities in hepatocellular carcinoma.
  • Collaborating on the ACTICCA-1 international trial in the rare cancers of gallbladder and biliary tract.
  • Collaboration on rectal studies including DYNAMIC-Rectal, SPAR and RENO study.
  • Implementing nutrition and patient reported outcomes from concept development.
  • Philanthropic funding dedicated to support RANDOMS, a substudy of MASTERPLAN, investigating a standard nutrition instrument used by dietitians to assess malnutrition against the gold standard.
  • Development of suitable study designs to fill gaps in research for early-stage oesophageal cancer by way of the Idea Generation Workshop.

Watch Dr Lorraine Chantrill, AGITG and GI Cancer Institute Chair, and Professor Steve Ackland, AGITG Director, discuss the AGITG research priorities:

 

Learn more about the AGITG

Share